India's Pharmaceutical Exports

Country Profile

Burkina Faso

Burkina Faso is a growing market for Indian pharmaceuticals — $45.4M in FY 2025–26, with 2.3× growth over the past decade. Medicines accounts for 70% of shipments, with vaccines contributing $12.9M. The compound annual growth rate since FY2015 stands at 8.0%.

🇧🇫 $45.4M · 2.3× growth since FY2015 · 8.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$45.4M
Exports FY2025–26 DGCIS
2.3×
Growth FY2015→2026
8.0%
CAGR FY2015→2026
70%
Medicines Share
5
Product Categories Supplied
Burkina Faso is a growing market for Indian pharmaceuticals — $45.4M in FY 2025–26, with 2.3× growth over the past decade. Medicines accounts for 70% of shipments, with vaccines contributing $12.9M. The compound annual growth rate since FY2015 stands at 8.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $31.9M (70.2%) Vaccines $12.9M (28.5%) Surgical & Hospital Supplies $466K (1.0%) Medicine Ingredients $97K (0.2%) Traditional & Herbal $9K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Burkina Faso in the RBI overseas direct investment dataset (2011–2026).